The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Re: Husband Stage IV- BRAF MEK trial – any info?

Forums General Melanoma Community Husband Stage IV- BRAF MEK trial – any info? Re: Husband Stage IV- BRAF MEK trial – any info?

    killmel
    Participant

      Hi,

      I understand that the BRAF/MEK is so new there are no studies. The Braf/MEK combo trial is a phase 1 and will take time to gather the resuts. Safety & dosage escalation is needed to be analyzed in Phase 1 not to mention side effects. Anyone on this trial is brave because this is a " unknown"  COMBO.

      Emily, who is your integrative oncologist and what city does he work from???? I have been looking for integrative oncologist in southern california for a long time. Anyone know of one? Is there a professional oraganization these types of doctors belong to???

      I wish you great success with this trial. May your husband get NED quickly.

    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.